Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 8451–8500 of 75459
on the Separation Date, Thomas Perone will cease serving as the Company’s General Counsel, Chief Compliance Officer and Corporate Secretary
As of the Effective Time, Robert Fitzgerald, Timothy Eriksen and Bradley Tirpak each ceased to be directors of the Company and members of any committee of the Company’s board of directors.
As of the Effective Time, Robert Fitzgerald, Timothy Eriksen and Bradley Tirpak each ceased to be directors of the Company and members of any committee of the Company’s board of directors.
As of the Effective Time, Robert Fitzgerald, Timothy Eriksen and Bradley Tirpak each ceased to be directors of the Company and members of any committee of the Company’s board of directors.
On June 24, 2024, Davinder Singh, the Chief Financial Officer of Tucows Inc. (the “Company”) informed the Board of Directors of the Company (“Board”) of his decision to voluntarily resign from his position to pursue other professional opportunities.
The Company and Mr. Richie mutually agreed that Mr. Richie's resignation will be effective as of July 8, 2024.
On June 26, 2024, each of Mark Bonyhadi and Edward Niemzyck submitted his respective resignation to the board of directors of TC Biopharm (Holdings) PLC (the “Company”), effective immediately.
On June 26, 2024, each of Mark Bonyhadi and Edward Niemzyck submitted his respective resignation to the board of directors of TC Biopharm (Holdings) PLC (the “Company”), effective immediately.
On June 26, 2024, James P. Geiskopf, a member of the Board of Directors of MetaWorks Platforms, Inc. and Chairman of the Audit Committee thereof, notified the Company of his intention to resign from the Company’s Board of Directors, effective June 28, 2024.
On June 26, 2024, Mr. Jack Kenny notified Biomerica, Inc. (the "Company") of his resignation as a member of the board of directors of the Company (the "Board") and all committees thereof, and as the Company’s Chairman of the Board, effective immediately.
On June 26, 2024, Gurminder Bedi, a Class I director of Blue Bird Corporation (the “Company”), informed our Chairman of the Board that he was resigning from our Board of Directors, effective immediately.
Joseph J. D'Ambrisi will resign as Executive Vice President, Head of Electronics and a named executive officer of the Company, effective July 1, 2024.
On June 25, 2024, Dr. Hong Wang informed the Board of Directors (the “Board”) of HF Foods Group Inc. (the “Company”) of his intention to resign from the Board and all committees thereof, effective June 28, 2024.
Effective June 28, 2024, the Company accepted the resignation of Chi Wai ( Michael) Woo as the CEO, CFO, President, Treasurer, and as a member of the Company’s Board of Directors.
Effective June 26, 2024, Brian L, Ferdinand, our company’s founder, and our former chairman of the board and chief executive officer, resigned as a member of the board.
Douglas L. Peterson will be retiring as Chief Executive Officer and President of the Company, effective as of November 1, 2024
Marc Maun, Executive Vice President – Regional Banking, has announced plans to step down from his current position effective March 31, 2025.
On June 26, 2024, the Board of Directors voted to accept the resignations of Mr. Collins and Mr. Orr, effective immediately.
On June 26, 2024, the Board of Directors voted to accept the resignations of Mr. Collins and Mr. Orr, effective immediately.
On June 25, 2024, Jin-Long Chen submitted his resignation as a director of Tenaya Therapeutics, Inc.
On June 27, 2024, the Compensation Committee (the “Committee”) of Aspira Women’s Health Inc. (the “Company”) determined that a personal civil matter interfered with Dr. Torsten Hombeck’ s ability to continue to serve as the Company’s Chief Financial Officer.
On June 21, 2024, Jason Throne informed IDEAYA Biosciences, Inc. (the “Company”) of his voluntary resignation from his positions as Chief Legal Officer and Secretary of the Company.
On June 27, 2024, U.S. Bancorp (the “Company”) announced certain organizational changes, including that Timothy A. Welsh will cease to serve as Vice Chair, Consumer and Business Banking, effective July 31, 2024.
At the Effective Time, pursuant to the Merger Agreement, Tim Adams, Jason Blessing, Baljit Dail, Kimberly DeCarlis, Melissa Fisher, Manisha Gulati, Alan Henricks, Scott Reese and Dave Yarnold, each of whom was a director of Model N as of immediately prior to the Effective Time, ceased to be a director of Model N and a member of any committee of Model N’s Board of Directors, and the directors of Merger Sub immediately prior to the Effective Time became the directors of Model N.
At the Effective Time, pursuant to the Merger Agreement, Tim Adams, Jason Blessing, Baljit Dail, Kimberly DeCarlis, Melissa Fisher, Manisha Gulati, Alan Henricks, Scott Reese and Dave Yarnold, each of whom was a director of Model N as of immediately prior to the Effective Time, ceased to be a director of Model N and a member of any committee of Model N’s Board of Directors, and the directors of Merger Sub immediately prior to the Effective Time became the directors of Model N.
At the Effective Time, pursuant to the Merger Agreement, Tim Adams, Jason Blessing, Baljit Dail, Kimberly DeCarlis, Melissa Fisher, Manisha Gulati, Alan Henricks, Scott Reese and Dave Yarnold, each of whom was a director of Model N as of immediately prior to the Effective Time, ceased to be a director of Model N and a member of any committee of Model N’s Board of Directors, and the directors of Merger Sub immediately prior to the Effective Time became the directors of Model N.
At the Effective Time, pursuant to the Merger Agreement, Tim Adams, Jason Blessing, Baljit Dail, Kimberly DeCarlis, Melissa Fisher, Manisha Gulati, Alan Henricks, Scott Reese and Dave Yarnold, each of whom was a director of Model N as of immediately prior to the Effective Time, ceased to be a director of Model N and a member of any committee of Model N’s Board of Directors, and the directors of Merger Sub immediately prior to the Effective Time became the directors of Model N.
At the Effective Time, pursuant to the Merger Agreement, Tim Adams, Jason Blessing, Baljit Dail, Kimberly DeCarlis, Melissa Fisher, Manisha Gulati, Alan Henricks, Scott Reese and Dave Yarnold, each of whom was a director of Model N as of immediately prior to the Effective Time, ceased to be a director of Model N and a member of any committee of Model N’s Board of Directors, and the directors of Merger Sub immediately prior to the Effective Time became the directors of Model N.
At the Effective Time, pursuant to the Merger Agreement, Tim Adams, Jason Blessing, Baljit Dail, Kimberly DeCarlis, Melissa Fisher, Manisha Gulati, Alan Henricks, Scott Reese and Dave Yarnold, each of whom was a director of Model N as of immediately prior to the Effective Time, ceased to be a director of Model N and a member of any committee of Model N’s Board of Directors, and the directors of Merger Sub immediately prior to the Effective Time became the directors of Model N.
At the Effective Time, pursuant to the Merger Agreement, Tim Adams, Jason Blessing, Baljit Dail, Kimberly DeCarlis, Melissa Fisher, Manisha Gulati, Alan Henricks, Scott Reese and Dave Yarnold, each of whom was a director of Model N as of immediately prior to the Effective Time, ceased to be a director of Model N and a member of any committee of Model N’s Board of Directors, and the directors of Merger Sub immediately prior to the Effective Time became the directors of Model N.
At the Effective Time, pursuant to the Merger Agreement, Tim Adams, Jason Blessing, Baljit Dail, Kimberly DeCarlis, Melissa Fisher, Manisha Gulati, Alan Henricks, Scott Reese and Dave Yarnold, each of whom was a director of Model N as of immediately prior to the Effective Time, ceased to be a director of Model N and a member of any committee of Model N’s Board of Directors, and the directors of Merger Sub immediately prior to the Effective Time became the directors of Model N.
At the Effective Time, pursuant to the Merger Agreement, Tim Adams, Jason Blessing, Baljit Dail, Kimberly DeCarlis, Melissa Fisher, Manisha Gulati, Alan Henricks, Scott Reese and Dave Yarnold, each of whom was a director of Model N as of immediately prior to the Effective Time, ceased to be a director of Model N and a member of any committee of Model N’s Board of Directors, and the directors of Merger Sub immediately prior to the Effective Time became the directors of Model N.
David S. Smith announced his decision to retire from his positions as Vice President, Chief Financial Officer and Treasurer of AstroNova, Inc.
On June 26, 2024, Jessie English, PhD notified the Chair of the Board of Directors (the “Board”) of Sensei Biotherapeutics, Inc. (the “Company”) of her decision to resign from the Board, effective July 1, 2024.
Effective June 21, 2024, Anna Zhou resigned from her positions as chief executive officer, company secretary and member of the board of directors (the “Board”) of Chenghe Acquisition II Co. (the “Company”).
On June 27, 2024, Todd Dissinger, Chief Financial Officer (principal financial officer) of Natural Grocers by Vitamin Cottage, Inc. (the “Company”) and its wholly owned subsidiary Vitamin Cottage Natural Food Markets, Inc., notified the Company that he intends to retire from the Company effective on or about December 31, 2024.
On June 24, 2024, Ken Plunk, Senior Vice President and Chief Financial Officer of J & J Snack Foods Corp. (the “Company”), notified the Company of his decision to retire from the Company effective December 31, 2024.
On June 26, 2024, Joseph Risico notified the Board of Directors (the “Board”) of the Company of his decision to resign as Co-Chief Executive Officer of the Company and from the Board, effective as of June 26, 2024.
announced today the resignation of Ahmad Moradi as its Chairman of the Board.
each of Guy Yachin, Dr. David Sidransky and Mario Philips did not stand for re-election at the Annual Meeting. Accordingly, the terms of each of Mr. Yachin, Dr. Sidransky and Mr. Philips on the Board of Directors ended effective as of June 27, 2024.
each of Guy Yachin, Dr. David Sidransky and Mario Philips did not stand for re-election at the Annual Meeting. Accordingly, the terms of each of Mr. Yachin, Dr. Sidransky and Mr. Philips on the Board of Directors ended effective as of June 27, 2024.
each of Guy Yachin, Dr. David Sidransky and Mario Philips did not stand for re-election at the Annual Meeting. Accordingly, the terms of each of Mr. Yachin, Dr. Sidransky and Mr. Philips on the Board of Directors ended effective as of June 27, 2024.
On June 21, 2024, Harry Schulman, a director of the Company, notified the Company that he was resigning from the Board, effective June 30, 2024
On June 21, 2024, W. Kip Speyer informed Bright Mountain Media, Inc. (the “Company”) that he will retire from his position as Chairman and as a member of the Board of Directors (the “Board”) of the Company effective June 30, 2024
On June 26, 2024, Timothy O’Brien and Charles S. Pearson, Jr. notified the Board that they will each resign as a director of the Company, effective June 26, 2024.
On June 26, 2024, Timothy O’Brien and Charles S. Pearson, Jr. notified the Board that they will each resign as a director of the Company, effective June 26, 2024.
On June 27, 2024, Akshay Vaishnaw informed the Board of Directors (the “Board”) of Editas Medicine, Inc. (the “Company”) of his resignation from the Board effective as of June 30, 2024.
Mr. Smith will step down from his role as Executive Vice President and Chief Financial Officer effective December 1, 2024, and will continue thereafter as Executive Vice President of McCormick to assist with the transition until his retirement from McCormick on February 28, 2025.
On June 25, 2024, Anthony K. Anderson provided AAR CORP. (the “Company”) notice of his decision to not stand for re-election to the Board of Directors of the Company at the Company’s next annual meeting of stockholders to be held on September 17, 2024.
On June 24, 2024, Winthrop Watson, President and Chief Executive Officer (CEO) of the Federal Home Loan Bank of Pittsburgh (Bank), notified the Bank’s Board of Directors (Board) that he intends to retire from the Bank, effective December 31, 2024.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.